Ann Lab Med.  2015 Jan;35(1):57-61. 10.3343/alm.2015.35.1.57.

Detection of the Efflux-Mediated Erythromycin Resistance Transposon in Streptococcus pneumoniae

• Azadegan A
• Ahmadi A
• Lari AR
• Talebi M

• KMID: 2363148
• DOI: http://doi.org/10.3343/alm.2015.35.1.57

Abstract

BACKGROUND
The present analysis focuses on phenotypic and genotypic characterizations of efflux-mediated erythromycin resistance in Streptococcus pneumoniae due to an increase in macrolide resistance in S. pneumoniae worldwide.
METHODS
We investigated the prevalence of efflux-mediated erythromycin resistance and its relevant genetic elements from 186 specimens of S. pneumonia isolated from clinical and normal flora from Tehran, Iran. The presence of erythromycin resistance genes was tested by PCR with two sets of primers, specific for erm(B) and mef(A/E), and their genetic elements with tetM, xis, and int genes. Isolates were typed with the BOX PCR method and tested for resistance to six antibiotics.
RESULTS
Antibiotic susceptibility tests revealed that 100% and 47% isolates were resistant to tetracycline and erythromycin, respectively. The erythromycin and clindamycin double-disc diffusion test for macrolide-lincosamide-streptograminB (MLSB) resistance phenotype showed 74 (84%) isolates with the constitutive MLSB phenotype and the remaining with the M phenotype. BOX PCR demonstrated the presence of 7 types in pneumococci with the M phenotype. Fourteen (16%) isolates with the M phenotype harbored mef(A/E), tetM, xis, and int genes.
CONCLUSIONS
The present results suggest dissemination of polyclonal groups of S. pneumoniae with the M phenotype carrying resistance genes attributed to transposon 2009.

Keyword

Erythromycin; mef(A/E); Streptococcus pneumoniae

MeSH Terms

Anti-Bacterial Agents/*pharmacology
Bacterial Proteins/genetics
DNA, Bacterial/metabolism
Drug Resistance, Multiple, Bacterial/*genetics
Erythromycin/*pharmacology
Genotype
Humans
Microbial Sensitivity Tests
Phenotype
Pneumococcal Infections/microbiology/pathology
Polymerase Chain Reaction
Streptococcus pneumoniae/*drug effects/*genetics/isolation & purification
Tetracycline/pharmacology
Anti-Bacterial Agents
Bacterial Proteins
DNA, Bacterial
Erythromycin
Tetracycline

Reference

1. Henderson KL, Muller-Pebody B, Blackburn RM, Johnson AP. Reduction in erythromycin resistance in invasive pneumococci from young children in England and Wales. J Antimicrob Chemother. 2010; 65:369–370. PMID: 20007730.

2. J J, M T N, M D MN, M SN, M Y R, J F, et al. Prevalence of macrolide resistance and in vitro activities of six antimicrobial agents against clinical isolates of Streptococcus pneumoniae from a multi-center surveillance in Malaysia. Med J Malaysia. 2013; 68:119–124. PMID: 23629556.

3. Xu X, Cai L, Xiao M, Kong F, Oftadeh S, Zhou F, et al. Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates. Antimicrob Agents Chemother. 2010; 54:1152–1159. PMID: 20065057.

4. Pihlajamäki M, Kataja J, Seppälä H, Elliot J, Leinonen M, Huovinen P, et al. Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother. 2002; 46:654–658. PMID: 11850244.

5. Taha N, Araj GF, Wakim RH, Kanj SS, Kanafani ZA, Sabra A, et al. Genotypes and serotype distribution of macrolide resistant invasive and non-invasive Streptococcus pneumoniae isolates from Lebanon. Ann Clin Microbiol Antimicrob. 2012; 11:2. PMID: 22248318.

6. Sangvik M, Littauer P, Simonsen GS, Sundsfjord A, Dahl KH. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway. J Antimicrob Chemother. 2005; 56:841–846. PMID: 16172106.

7. Montanari MP, Cochetti I, Mingoia M, Varaldo PE. Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother. 2003; 47:2236–2241. PMID: 12821474.

8. Cochetti I, Vecchi M, Mingoia M, Tili E, Catania MR, Manzin A, et al. Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I). Antimicrob Agents Chemother. 2005; 49:4999–5006. PMID: 16304164.

9. Calatayud L, Ardanuy C, Tubau F, Rolo D, Grau I, Pallarés R, et al. Serotype and genotype replacement among macrolide-resistant invasive Pneumococci in adults: mechanisms of resistance and association with different transposons. J Clin Microbiol. 2010; 48:1310–1316. PMID: 20147647.

10. Strålin K, Korsgaard J, Olcén P. Evaluation a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage. Eur Respir J. 2006; 28:568–575. PMID: 16737990.

11. Zhou L, Ma X, Gao W, Yao KH, Shen AD, Yu SJ, et al. Molecular characteristics of erythromycin-resistant Streptococcus pneumoniae from pediatric patients younger than five years in Beijing, 2010. BMC Microbiol. 2012; 12:228–238. PMID: 23043378.

12. Malhotra-Kumar S, Lammens C, Piessens J, Goossens H. Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci. Antimicrob Agents Chemother. 2005; 49:4798–4800. PMID: 16251336.

13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 23rd Informational supplement, M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute;2013.

14. Payne as DB, Sun A, Butler JC, Singh SP, Hollingshead SK, Briles DE. PspA family typing and PCR-based DNA fingerprinting with BOX A1R primer of pneumococci from the blood of patients in the USA with and without sickle cell disease. Epidemiol Infect. 2005; 133:173–178. PMID: 15724724.

15. de la Pedrosa EG, Morosini MI, van der Linden M, Ruiz-Garbajosa P, Galán JC, Baquero F, et al. Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B). Antimicrob Agents Chemother. 2008; 52:1964–1969. PMID: 18362188.

16. Marchandin H, Jean-Pierre H, Jumas-Bilak E, Isson L, Drouillard B, Darbas H, et al. Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France. Pathol Biol (Paris). 2001; 49:522–527. PMID: 11642013.

17. Bae S, Lee K. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea. Diagn Microbiol Infect Dis. 2009; 63:213–216. PMID: 19097840.

18. McGee L, Klugman KP, Wasas A, Capper T, Brink A. Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. Antimicrob Agents Chemother. 2001; 45:1595–1598. PMID: 11302838.

19. Cochetti I, Tili E, Vecchi M, Manzin A, Mingoia M, Varaldo PE, et al. New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci. J Antimicrob Chemother. 2007; 60:127–131. PMID: 17483548.

20. Felmingham D, Cantón R, Jenkins SG. Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004. J Infect. 2007; 55:111–118. PMID: 17568680.

21. Hsueh PR, Teng LJ, Lee LN, Yang PC, Ho SW, Luh KT. Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. J Clin Microbiol. 1999; 37:897–901. PMID: 10074498.

22. Calatayud L, Ardanuy C, Cercenado E, Fenoll A, Bouza E, Pallares R, et al. Serotypes, clones, and mechanisms of resistance of erythromycin-resistant Streptococcus pneumoniae isolates collected in Spain. Antimicrob Agents Chemother. 2007; 51:3240–3246. PMID: 17606677.